As the landscape of breast cancer care continues to evolve, the focus for patients is shifting from...
Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...
Disappointing Phase III results for ArriVent BioPharma’s lead candidate, firmonertinib, in the treatment of non-small cell lung...
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, widely...
HUNTSVILLE, AL — In the rapidly shifting landscape of modern oncology, the distance between a high-tech laboratory...
NEW YORK CITY — On a Tuesday that bridged the gap between the morning commute and a...
OTTAWA – As the landscape of oncology shifts toward increasingly personalized medicine, a comprehensive new national survey...
AMMAN – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded the...
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company anchored by the prestige...
In a significant move that promises to reshape the landscape of urological care, Zenflow, a California-based medical...
